Abiopharma

Cue Biopharma Receives FDA Feedback on Pre-IND Briefing Document Reinforcing Company’s Intention to Advance IND Submission for CUE-401 to Address Unmet Need in the Treatment of Autoimmune Disease

New Form 4 - Perimeter Solutions, Inc. Filed: 2025-06-24 AccNo: 0001880319-25-000088 Size: 4 KB

New Form 4 - Perimeter Solutions, Inc. Filed: 2025-06-24 AccNo: 0001880319-25-000087 Size: 4 KB

New Form 4 - Perimeter Solutions, Inc. Filed: 2025-06-24 AccNo: 0001880319-25-000086 Size: 4 KB

New Form 4 - MADRIGAL PHARMACEUTICALS, INC. Filed: 2025-06-24 AccNo: 0001628280-25-032863 Size: 7 KB

New Form 4 - MADRIGAL PHARMACEUTICALS, INC. Filed: 2025-06-24 AccNo: 0001628280-25-032861 Size: 7 KB

New Form SCHEDULE 13D/A - Nautilus Biotechnology, Inc. Filed: 2025-06-24 AccNo: 0001104659-25-062136 Size: 10 KB

New Form 424B5 - Forte Biosciences, Inc. Filed: 2025-06-24 AccNo: 0001193125-25-145774 Size: 586 KB

New Form 144 - Brookdale Senior Living Inc. Filed: 2025-06-24 AccNo: 0001969223-25-000468 Size: 8 KB

New Form 4 - MADRIGAL PHARMACEUTICALS, INC. Filed: 2025-06-24 AccNo: 0001628280-25-032855 Size: 7 KB

Coherent to Showcase Innovative Products, Technologies, and Thought Leadership at Laser World of Photonics 2025

New Form 4 - Verastem, Inc. Filed: 2025-06-24 AccNo: 0001104659-25-062131 Size: 5 KB

New Form 11-K - BALCHEM CORP Filed: 2025-06-24 AccNo: 0000009326-25-000008 Size: 177 KB

New Form 4 - MADRIGAL PHARMACEUTICALS, INC. Filed: 2025-06-24 AccNo: 0000950170-25-089481 Size: 26 KB

New Form 8-K - Synaptogenix, Inc. Filed: 2025-06-24 AccNo: 0001104659-25-062128 Size: 206 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits